213 related articles for article (PubMed ID: 35804895)
1. Single B Cell Gene Co-Expression Networks Implicated in Prognosis, Proliferation, and Therapeutic Responses in Non-Small Cell Lung Cancer Bulk Tumors.
Ye Q; Guo NL
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804895
[TBL] [Abstract][Full Text] [Related]
2. A Multi-Omics Network of a Seven-Gene Prognostic Signature for Non-Small Cell Lung Cancer.
Ye Q; Falatovich B; Singh S; Ivanov AV; Eubank TD; Guo NL
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008645
[TBL] [Abstract][Full Text] [Related]
3. Hub Genes in Non-Small Cell Lung Cancer Regulatory Networks.
Ye Q; Guo NL
Biomolecules; 2022 Nov; 12(12):. PubMed ID: 36551208
[TBL] [Abstract][Full Text] [Related]
4. Immune-Omics Networks of
Ye Q; Singh S; Qian PR; Guo NL
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503105
[TBL] [Abstract][Full Text] [Related]
5. Multi-Omics Immune Interaction Networks in Lung Cancer Tumorigenesis, Proliferation, and Survival.
Ye Q; Hickey J; Summers K; Falatovich B; Gencheva M; Eubank TD; Ivanov AV; Guo NL
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499305
[TBL] [Abstract][Full Text] [Related]
6. Identifying the hub genes in non-small cell lung cancer by integrated bioinformatics methods and analyzing the prognostic values.
Wang T; Chen X; Jing F; Li Z; Tan H; Luo Y; Shi H
Pathol Res Pract; 2021 Dec; 228():153654. PubMed ID: 34749208
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analyses of the heterogeneity and prognostic significance of tumor-infiltrating immune cells in non-small-cell lung cancer: Development and validation of an individualized prognostic model.
Pang Z; Chen X; Wang Y; Wang Y; Yan T; Wan J; Du J
Int Immunopharmacol; 2020 Sep; 86():106744. PubMed ID: 32623229
[TBL] [Abstract][Full Text] [Related]
8. Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy.
Li C; Pan J; Luo J; Chen X
BMC Pulm Med; 2021 Nov; 21(1):389. PubMed ID: 34844602
[TBL] [Abstract][Full Text] [Related]
9. Identification of Prognostic and Chemopredictive microRNAs for Non-Small-Cell Lung Cancer by Integrating SEER-Medicare Data.
Ye Q; Putila J; Raese R; Dong C; Qian Y; Dowlati A; Guo NL
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299277
[TBL] [Abstract][Full Text] [Related]
10. Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer.
Wang XW; Guo QQ; Wei Y; Ren KM; Zheng FS; Tang J; Zhang HY; Zhao JG
Oncol Rep; 2019 Dec; 42(6):2402-2415. PubMed ID: 31638248
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
Li B; Cui Y; Diehn M; Li R
JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
[TBL] [Abstract][Full Text] [Related]
12. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
13. Comprehensive analysis of an immune infiltrate-related competitive endogenous RNA network reveals potential prognostic biomarkers for non-small cell lung cancer.
Yang CZ; Hu LH; Huang ZY; Deng L; Guo W; Liu S; Xiao X; Yang HX; Lin JT; Sun LL; Lin LZ
PLoS One; 2021; 16(12):e0260720. PubMed ID: 34855841
[TBL] [Abstract][Full Text] [Related]
14. Identification of the ferroptosis-related long non-coding RNAs signature to improve the prognosis prediction and immunotherapy response in patients with NSCLC.
Li M; Zhang Y; Fan M; Ren H; Chen M; Shi P
BMC Med Genomics; 2021 Dec; 14(1):286. PubMed ID: 34861872
[TBL] [Abstract][Full Text] [Related]
15. Molecular Analysis of
Ye Q; Mohamed R; Dakhlallah D; Gencheva M; Hu G; Pearce MC; Kolluri SK; Marsh CB; Eubank TD; Ivanov AV; Guo NL
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916522
[TBL] [Abstract][Full Text] [Related]
16. Gene co-expression modules integrated with immunoscore predicts survival of non-small cell lung cancer.
Li XT; Zhang JT; Yan HH; Su J; Cheng ML; Sun QH; Zhong WZ; Wu YL; Zhang DX; Hou DJ
Cancer Treat Res Commun; 2021; 26():100297. PubMed ID: 33385734
[TBL] [Abstract][Full Text] [Related]
17. Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis.
Gong K; Zhou H; Liu H; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L
Technol Cancer Res Treat; 2021; 20():15330338211060202. PubMed ID: 34825846
[No Abstract] [Full Text] [Related]
18. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the Significance of Immune Cell Infiltration and Prognosis of Non-Small-Cell Lung Cancer by Bioinformatics.
Sun H; Sui B; Li Y; Yan J; Cao M; Zhang L; Liu S
J Healthc Eng; 2021; 2021():3284186. PubMed ID: 34603645
[TBL] [Abstract][Full Text] [Related]
20. Single-cell transcriptome and antigen-immunoglobin analysis reveals the diversity of B cells in non-small cell lung cancer.
Chen J; Tan Y; Sun F; Hou L; Zhang C; Ge T; Yu H; Wu C; Zhu Y; Duan L; Wu L; Song N; Zhang L; Zhang W; Wang D; Chen C; Wu C; Jiang G; Zhang P
Genome Biol; 2020 Jun; 21(1):152. PubMed ID: 32580738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]